Original article
Cytokines in symptomatic asthma airways☆,☆☆

https://doi.org/10.1016/0091-6749(92)90218-QGet rights and content

Abstract

To determine whether cytokines are generated in vivo in subjects with asthma, we have measured cytokine (tumor necrosis factor [TNF], granulocyte-macrophage—colony-stimulating factor [GM—CSF], interleukin [IL]-1α, IL-1β, IL-2, IL-4, and IL-6) in the airways of subjects with symptomatic (N = 24) and asymptomatic (N = 9) asthma with immunoassays (GM-CSF, IL-1α, IL-1β, IL-2, ad IL-4) or bioassays (TNF and IL-6) and the polymerase chain reaction (IL-1β and TNF). Significant levels of TNF (578 ± 917 pg/ml versus 24 ± 29 pg/ml) (p = 0.01), GM-CSF (24 ± 41 pg/ml versus <8 pg/ml) (p = 0.02), and IL-6 (225 ± 327 pg/ml versus 7 ± 12 pg/ml) (p = 0.01), but not IL-1α or IL-4, were detected in the bronchoalveolar lavage fluid (BALF) of patients with symptomatic compared with BALF of patients with asymptomatic asthma. Levels of IL-1β (266 ± 270 pg/ml versus <20 pg/ml) (p = 0.001) and IL-2 (1.4 ± 2.8 ng/ml versus <0.3 ng/ml) (p = 0.05) in BALF in patients with asymptomatic compared with that in BALF levels in patients with asymptomatic asthma suggested activation of alveolar macrophages and T cells. Thus, in episodes of asthma, several cytokines, including TNF, GM-CSF, IL-1β, IL-2, and IL-6 are detectable in BALF.

References (27)

  • D.H. Broide et al.

    Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway

    J Allergy Clin Immunol

    (1991)
  • S. Mattoli et al.

    Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma

    J Allergy Clin Immunol

    (1991)
  • R. Djukanovic et al.

    Mucosal inflammation in asthma

    Am Rev Respir Dis

    (1990)
  • S.E. Wenzel et al.

    Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma

    Am Rev Respir Dis

    (1988)
  • E. Fregis et al.

    The eosinophil and the pathophysiology of asthma [Postgrad course]

    J Allergy Clin Immunol

    (1986)
  • K.A. Smith

    Interleukin-2: inception, impact, and implications

    Science

    (1988)
  • S.-S.J. Sung et al.

    Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T-lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody

    J Exp Med

    (1988)
  • Y. Martinet et al.

    Differential expression of tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes

    Am Rev Respir Dis

    (1988)
  • J.-F. Bernaudin et al.

    Demonstration by in situ hybridization of dissimilar IL-1β gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide

    J Immunol

    (1988)
  • S.M. Smith et al.

    Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor

    Am J Respir Cell Mol Biol

    (1990)
  • W.F. Owen et al.

    Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts

    J Exp Med

    (1987)
  • M.E. Rothenberg et al.

    Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3

    J Clin Invest

    (1988)
  • D.S. Silberstein et al.

    Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colonystimulating factor

    J Immunol

    (1986)

    • Cited by (0)

    ☆

    Supported in part by National Institutes of Health Grants AI 29974, AI 17268, and AI 20476.

    ☆☆

    Presented in part at the Annual Meeting of The American Thoracic Society, Anaheim, Calif., May 1991.

    View full text
    Copyright © 1992 Published by Mosby, Inc.